SEC Form D · filed March 19, 2021
Camp4 Therapeutics Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Amir Nashat · CAMBRIDGE, MADirectorJosh Mandel-Brehm · CAMBRIDGE, MAExec · DirectorMichael Higgins · CAMBRIDGE, MADirectorKelly Gold · CAMBRIDGE, MAExecJorge Conde · CAMBRIDGE, MADirectorSteve Holtzman · CAMBRIDGE, MADirectorRichard Young · CAMBRIDGE, MADirectorAlfica Sehgal · CAMBRIDGE, MAExecCaleb Moore · CAMBRIDGE, MAExecPaula Ragan · CAMBRIDGE, MADirectorDavid Bumcrot · CAMBRIDGE, MAExecAriel L. Fainsod · Calgary, Alberta, CanadaDirectorNigel R. Cameron · Tampa, FLDirectorLisa Henneberry · Denver, COExecShannon B. Stuckenberg · Tampa, FLDirectorChris L. Claussen · Calgary, Alberta, CanadaExecDavid Schwartz · Newton Centre, MADirectorJohn P. Sumrall · Tampa, FLExec · DirectorSteven R. Kwast · Tampa, FLExecDavid J. Stuckenberg · Tampa, FLDirectorFrank J. Stonebanks · Southlake, TXExecMichelle Robson · Denver, CODirectorMandeep Mundae · London, United KingdomDirectorPatrick L. Cavanagh · Cold Spring Harbor, NYDirectorJoseph L. Mcaleese · Cold Spring Harbor, NYDirectorRichard L. Baum, Jr · Cold Spring Harbor, NYExec · DirectorStephen L. Mance · Cold Spring Harbor, NYExecGordon L. Bonfield · Cold Spring Harbor, NYDirectorGeorge Gong · New York, NYExecHan Shen · New York, NYExecYang Pan · New York, NYDirectorIsaac Barchas · West Lafayette, INDirectorSunil Singhal, M.D · West Lafayette, INExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗